BIBITEC

BIBITEC is a German contract manufacturing organization focused on biological drug development and GMP-compliant production of recombinant proteins in mammalian cell culture. The company provides process development and manufacturing services for biopharmaceutical active ingredients and supports clients from early development through finished drug product supply via partner networks. BIBITEC is licensed to manufacture materials for clinical trials through Phase 3 and positions itself as a one-stop provider across the biologics value chain. It operates as a wholly owned subsidiary of Nordmark Pharma and originated as a spin-off from the University of Bielefeld.